C-Glucosylchromones from Kunzea ambigua
J ournal of Natural Products, 2004, Vol. 67, No. 3 415
Ku n zea ch r om on e C (4): colorless fine needles, mp 212-
EBV-EA Assa y. The inhibition of EBV-EA activation was
assayed using Raji cells (virus nonproducer), the EBV genome-
carrying lymphoblastoid cells derived from Burkitt’s lym-
phoma, which were cultured in 10% fetal bovine serum (FBS)
in RPMI-1640 medium (Nissui). The indicator cells (Raji, 1 ×
106/mL) were incubated at 37 °C for 48 h in the medium (1
mL) containing n-butyric acid (4 mM), TPA [20 ng (32 pM) in
DMSO 2 µL] as inducer, and a known amount of test compound
in 5 µL of DMSO. Smears were made from the cell suspension,
and the activated cells that were stained by EBV-EA positive
serum were detected by a conventional indirect immunofluo-
rescens technique. In each assay, at least 500 cells were
counted, and the number of stained cells was recorded.
Triplicate assays were carried our for each compound. The
average EBV-EA induction of the test compound was expressed
as a relative ratio to the positive control experiment (100%)
with n-butyric acid plus TPA in which EA induction was
ordinarily 35%.
214 °C (from MeOH); [R]23 -87° (c 1, MeOH); UV (MeOH)
D
λmax (log ꢀ) 210 (4.73), 258 (4.45), 274 (4.23) nm; for 1H and
13C NMR spectral data, see Tables 2 and 3; ESIMS m/z 507
[M + H]+, 529 [M + Na]+; HRESIMS m/z 507.1193 [M + H]+
(C23H22O13+H, 507.1139).
Ku n zea ch r om on e D (5): pale yellow amorphous powder,
[R]23 -23° (c 1, MeOH); UV (MeOH) λmax (log ꢀ) 215 (4.74),
D
259 (4.33), 277 (4.32) nm; for 1H and 13C NMR spectral data,
see Tables 2 and 3; ESIMS m/z 659 [M + H]+; HRESIMS m/z
659.1238 [M + H]+ (C30H26O17+H, 659.1248).
Ku n zea ch r om on e E (6): colorless needles, mp 204-205
°C (from MeOH); [R]23 -135° (c 1, MeOH); UV (MeOH) λmax
D
(log ꢀ) 210 (4.72), 257 (4.40), 281 (4.25) nm; for 1H and 13C
NMR spectral data, see Tables 2 and 3; ESIMS m/z 507 [M +
H]+, 529 [M + Na]+; HRESIMS m/z 507.1085 [M + H]+
(C23H22O13+H, 507.1139).
Ku n zea ch r om on e F (7): pale yellow amorphous powder,
[R]23D -4° (c 1, MeOH); UV λmax (MeOH) nm (log ꢀ) 216 (4.78),
257 (4.39), 277 (4.34); for 1H and 13C NMR spectral data, see
Tables 2 and 3; ESIMS m/z 659 [M + H]+; HRESIMS m/z
659.1263 [M + H]+ (C30H26O17+H, 659.1248).
Ack n ow led gm en t. This work was supported in part by a
Grant-in-Aid for Scientific Research (no. 10557207) from the
Ministry of Education, Science, Sports and Culture, J apan.
Thanks are due to Mr. Y. Kitada of the Central Research
Laboratory of the Pola Corporation for kindly supplying plant
material. The NMR experiments were performed at the SC-
NMR Laboratory of Okayama University.
P a r tia l Hyd r olyses of 2-7 w ith Ta n n a se. A solution of
each compound (0.4-0.5 mg) in H2O (0.4 mL) was treated at
37 °C for an appropriate time with two drops of tannase, which
was obtained from Aspergillus niger, as described previously.16
After the addition of EtOH, the reaction mixture was evapo-
rated to dryness. The residue was analyzed by normal- and
reversed-phase HPLC. The liberated compounds in addition
to gallic acid from each compound were as follows and
identified respectively by co-chromatography with authentic
specimens: Biflorin (12) was obtained by hydrolysis of 4 (5
mg) with tannase and identified by comparison of the spectral
data with those reported in the literature.10 12: pale yellow
amorphous powder; 1H NMR (500 MHz, DMSO-d6) δ 13.39
(1H, s, 6-OH), 6.37 (1H, s, H-8), 6.16 (1H, s, H-3), 4.55 (1H, d,
J ) 10.0 Hz, Glc-H-1′), 3.0-4.1 (6H, m, Glu-H-2′-6′), 2.34 (3H,
s, CH3); ESIMS m/z 335 [M + H]+. Isobiflorin (13), which was
previously isolated from Eucalyptus cypellocarpa,17 was used
as standard sample upon comparison on HPLC.
2: reaction time 8 h; normal- and reversed-phase HPLC
(solvent C) resulted in peaks for 6-â-C-glucopyranosyl-5,7-
dihydroxy-2-isopropylchromone (8) and 6-â-C-(2′-galloylglu-
copyranosyl)-5,7-dihydroxy-2-isopropylchromone (9).
3: reaction time 24 h; normal- and reversed-phase HPLC
(solvent C) resulted in peaks for 8-â-C-glucopyranosyl-5,7-
dihydroxy-2-isopropylchromone (10) and 8-â-C-(2′-galloylglu-
copyranosyl)-5,7-dihydroxy-2-isopropylchromone (11).
4: reaction time 48 h; normal- and reversed-phase HPLC
(solvent B) resulted in peaks for biflorin (12).
Refer en ces a n d Notes
(1) David, H. J . J . PCT Int. Appl. 1997, 14 pp.
(2) Yazaki, Y. Phytochemistry 1977, 16, 138-139.
(3) Okuda, T.; Yoshida, T.; Hatano, T.; Yazaki, K.; Ashida, M. Phy-
tochemistry 1980, 21, 2871-2874.
(4) Mani, R.; Ramanathan, V.; Venkataraman, K. J . Sci. Ind. Res. 1956,
15B, 490-495.
(5) Foo, L. Y.; Lu, Y.; Molan, A. L.; Woodfield, D. R.; McNabb, W. C.
Phytochemistry 2000, 54, 539-548.
(6) Markham, K. R.; Ternai, B.; Stanley, R.; Geiger, H.; Mabry, T.
Tetrahedron 1978, 34, 1389-1397.
(7) Satake, T.; Kamiya, K.; Saiki, Y.; Hama, T.; Fujimoto, Y.; Endang,
H.; Umar, M. Phytochemistry 1999, 50, 303-306.
(8) Wollenweber, E.; Wehdea, R.; Dorra, M.; Langb, G.; Stevens, J . F.
Phytochemistry 2000, 55, 965-970.
(9) Ghisalberti, E. L. Phytochemistry 1996, 41, 7-22.
(10) Ghosal, S.; Kumar, Y.; Singh, S.; Ahad, K. Phytochemistry 1983, 22,
2591-2593.
(11) Tanaka, T.; Orii, Y.; Nonaka, G.; Nishioka, I. Chem. Pharm. Bull.
1993, 41, 1232-1237.
(12) Yoshizawa, S.; Horiuchi, H.; Fujiki, H.; Yoshida, T.; Okuda, T.;
Sugimura, T. Phytother. Res. 1987, 1, 44-47.
(13) Okabe, S.; Suganuma, M.; Imayoshi, Y.; Taniguchi, S.; Yoshida, T.;
Fujiki, H. Biol. Pharm. Bull. 2001, 24, 1145-1148.
(14) Ito, H.; Miyake, M.; Nishitani, E.; Mori, K.; Hatano, T.; Okuda, T.;
Konoshima, T.; Takasaki, M.; Kozuka, M.; Mukainaka, T.; Tokuda,
H.; Nishino, H.; Yoshida, T. Cancer Lett. 1999, 143, 5-13.
(15) Ito, Y.; Kawanishi, M.; Harayama, T.; Takabayashi, S. Cancer Lett.
1981, 12, 175-180.
(16) Yoshida, T.; Tanaka, K.; Chen, X.-M.; Okuda, T. Chem. Pharm. Bull.
1989, 37, 920-924.
(17) Ito, H.; Koreishi, M.; Tokuda, H.; Nishino, H.; Yoshida, T. J . Nat.
Prod. 2000, 63, 1253-1257.
5: reaction time 48 h; normal- and reversed-phase HPLC
(solvent B) resulted in peaks for biflorin (12) and kunzeach-
romone C (4).
6: reaction time 150 h; normal- and reversed-phase HPLC
(solvent B) resulted in peaks for isobiflorin (13).
7: reaction time 48 h; normal- and reversed-phase HPLC
(solvent B) resulted in peaks for isobiflorin (13) and kunzeach-
romone E (6).
NP030367S